Calcium Channel Blockers are also helpful in reducing multiple risks involved in the Parkinson’s disease. The calcium Channel blockers are in fact a group of specific drugs that people generally take for treating and controlling high blood pressure. This group of drugs is very popular among the patients of high blood pressure across the world.

A recent research study published in the February issue of the journal “Neurology” established this finding with sufficient evidences based on clinical trials.

Researchers conducted study with the help of almost 7,374 volunteers who were men and women both and were belonging to an age group of ‘over 40 years’. Selection of these men and women was on the basis of having the Parkinson’s disease or not. Meaning thereby, half of them were suffering from this disease and the rest one did not.

Among all the men and women, divided in to two groups, 50 percent volunteers were also suffering from high blood pressure and were undergoing its treatments that included the ‘calcium Channel blockers’, ACE inhibitors, AT-II antagonists, and beta blockers.

Researchers observed that the participants who were treating themselves with the calcium channel blockers for a long time for controlling their high blood pressure were found to be with lowered down risks of having Parkinson’s disease. The rate of such lowering down was calculated to be almost 23% compared to those participants who were not on these medications.

Such effects of lowering down the risks of Parkinson’s disease was however, not observed with same effects with the use of any other drugs like ACE inhibitors, AT II antagonists and beta blockers. Dr Christoph R. Meier , the lead researcher at the University Hospital Basel in Switzerland says,” no such association was seen for other high blood pressure medicines”.

Dr Christoph R. Meier believe that further extended research in to this area is really required as it would further help in exploring the explanations of why these ‘calcium channel Blockers’ act as a potential firewall against the risks of Parkinson’s disease and reduce the risks up to great extent at the same time. The future research would also be helpful in finding out the reasons for all other high blood pressure drugs not being effective in the same manner.

This article is the property of http://www.Healthpm.com
Copying and publishing any article from our site is strictly NOT allowed.